Abstract
The clinical and pathological features of the cardiotoxicity produced by antineoplastic antibiotics of the anthracycline type are reviewed. The mechanisms by which these changes are produced are discussed, and new data concerning the prevention of this cardiotoxicity are presented.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Bertazzoli, C., Sala, L., Solcia, E., & Ghione M. Experimental adriamycin cardiotoxicity prevented by ubiquinone in vivo in rabbits. IRCS Journal of Medical Scienee 3, 468 (1975).
Billingham, M. E., Bristow, M. R., Glatstein, E., Mason, J. W., Masek, M. A. & Daniels, J. R., Adriamycin cardiotoxicity: endomyocardial biopsy evidence of enhancement by irradiation. American Journal of Surgical Pathology 1, 17–23 (1977).
Billingham, M. E., Mason, J. W., Bristow, M. R. & Daniels, J. R. Anthracycline cardiomyopathy monitored by morphologic changes. Cancer Treatment Reports 62, 865–872 (1978).
Breed, J. G. S., Zimmerman, A. N. E., Dormans, J. A. M., & Pinedo, H. M. Failure of the antioxidant vitamin E to protect against adriamycin-induced cardiotoxicity in the rabbit. Cancer Research 40, 2033–2038 (1980).
Bristow, M. R., Mason, J. W., Billingham, M. E., & Daniels, J. R. Doxorubicin cardiomyopathy. Evaluation by phonocardiography, endomyocardial biopsy, and cardiac catheterization. Annals of Internal Medicine 88, 168–175 (1978).
Bristow, M. R., Minobe, W. A., Billingham, M. E., Marmor, J. B. Johnson, G. A., Ishimoto, B. M., Sageman, W. S. & Daniels, J. R. Anthracycline-associated cardiac and renal damage in rabbits: evidence for mediation by vasoactive substances. Laboratory Investigation 45, 157–168 (1981).
Bristow, M. R., Thompson, P. D., Martin, R. P., Mason, J. W., Billingham, M. E. & Harrison, D. C. Early anthracycline cardiotoxicity. American Journal of Medicine 65, 823–832 (1978).
Buja, L. M., Ferrans, V. J., & Maron, B. J. Intracytoplasmic junctions in cardiac muscle cells. American Journal of Pathology 74, 613–648 (1974).
Buja, L. M., Ferrans, V. J-, Mayer, R. J., Roberts, W. C. & Henderson, E. S. Cardiac ultrastructural changes induced by daunorubicin therapy. Cancer 32, 771–788 (1973).
Buja, L. M., Ferrans, V. J. & Rabson, A. S. Letter: Unusual nuclear alterations. Lancet 1, 402–403 (1974).
Caulfield, J. B., Shelton, R. W. & Burke, J. F. Cytotoxic effects of oxygen on striated muscle. Archives of Pathology 94, 127–132 (1972).
Chalcroft, S. C. W., Gavin, J. B. & Herdson, P. B. Fine structural changes in rat myocardium induced by daunorubicin. Pathology 5, 99–105 (1973).
Cortes, E. P., Lutman, G., Wanka, J., Wang, J. J., Pickren, J., Wallace, J. & Holland, J. F. Adriamycin (NSC-123127) cardiotoxicity. A clinicopathologic correlation. Cancer Treatment Reports 6, 215–225 (1975).
Daskal, Y., Woodard, C., Crooke, S. T. & Busch, H. Comparative ultrastructural studies of nucleoli of tumor cells treated with Adriamycin and the newer anthracyclines, Carminomycin and Marcellomycin. Cancer Research 38, 467–473 (1978).
Egorin, M. J., Hildebrand, R. C., Cimino, E. F. & Bachur, N. R. Cytofluorescence localization of adriamycin and daunorubicin. Cancer Research 34, 2243–2245 (1974).
El-Hage, A. N., Herman, E. H. & Ferrans, V. J. Reduction in the diabetogenic effect of alloxan in mice by treatment with the antineoplastic agent ICRF-187. Research Communications in Chemical Pathology and Pharmacology 33, 509–523 (1981).
Eltringham, J. R., Fajardo, L. F. & Stewart R. Adriamycin cardiomyopathy: enhanced cardiac damage in rabbits with combined drug and cardiac irradiation. Radiology 115, 471–472 (1975).
Fajardo, L. F., Eltringham, J. R. & Stewart, J. R. Combined cardiotoxicity of Adriamycin and X-radiation. Laboratory Investigation 34, 86–96 (1976).
Fajardo, L. F. & Stewart, J. R. Pathogenesis of radiation-induced myocardial fibrosis. Laboratory Investigation 29, 244–257 (1973).
Ferrans, V. J. Overview of cardiac pathology in relation to anthracycline cardiotoxicity. Cancer Treatment Reports 62, 955–961 (1978).
Ferrans, V. J. & Butany, J. W. Ultrastructural pathology of the heart. In Diagnostic Electron Microscopy, Vol. 4. B. Trump & R. Jones, Eds. New York: John Wiley & Sons, Inc. (in press, 1982).
Ferrans, V. J., Hibbs, R. G., Walsh, J. J. & Burch, G. E. Histo-chemical and electron microscopical studies on the cardiac necroses produced by sympathomimetic agents. Annals of the New York Academy of Sciences 156, 309–332 (1969).
Ferrans, V. J., Hibbs, R. G.., Weily, H. S., Weilbaecher, D. G., Walsh, J. J. & Burch, G. E. A histochemical and electron microscopic study of epinephrine-induced myocardial necrosis. Journal of Molecular and Cellular Cardiology 1, 11–22 (1970).
Ferrans, V. J., Thiedemann, K.-U., Maron, B. J. & Roberts, W. C. Spherical micropartides in human myocardium. An ultra-structural study. Laboratory Investigation 35, 349–368 (1976).
Franco-Browder, S., Guerrero, M., Gorodezky, M., Bravo, L. M. & Aceves, S. Lesiones miocárdicas producidas por liberadores de histamina en ratas. Archivos del Instituto de Cardiologia de Mexico 30, 720–728 (1960).
Gandolfi, A. Cardiotossicità cronica da adriamicina: studio morfologico ultrastrutturale sul miocardio ventricolare e sul sistema di conduzione del cuore di coniglio. Ateneo Parmense. Sezione 1. Acta Bio-Medica 47, 69–78 (1976).
Gilladoga, A. C., Manuel, C., Tan, C. C., Wollner, N. & Murphy, M. L. Cardiotoxicity of adriamycin (NSC-123127) in children. Cancer Chemotherapy Reports 6, 209–214 (1975).
Gilladoga, A. C., Manuel, C., Tan, C., Wollner, N., Sternberg, S. S. & Murphy, M. L. The cardiotoxicity of adriamycin and daunomycin in children. Cancer 37, 1070–1078 (1976).
Gosalvez, M., van Rossum, G. D. V., & Blanco, M. F. Inhibition of sodium-potassium-activated adenosine 5’-triphosphatase and ion transport by Adriamycin. Cancer Research 39, 257–261 (1979).
Halazun, J. F., Wagner, H. R., Gaeta, J. F. & Sinks, L. F. Daunorubicin cardiac toxicity in children with acute lymphocytic leukemia. Cancer 33, 545–554 (1974).
Herman, E. H. & Ferrans, V. J. Reduction of chronic doxorubicin cardiotoxicity in dogs by pretreatment with (±)-1,2-Bis (3,5-dioxopiperazinyl-l-yl) propane (ICRF-187). Cancer Research 41, 3436–3440 (1981).
Herman, E. H. & Ferrans, V. J. ICRF-187 reduction of chronic daunorubicin and doxorubicin cardiotoxicity in rabbits and beagle dogs. Chemioterccpia Oncologica 5, 37–41 (1981).
Herman, E. H., Ferrans, V. J., Jordan, W. & Ardalan, B. Reduction of chronic daunorubicin cardiotoxicity by ICRF-187 in rabbits. Research Communications in Chemical Pathology and Pharmacology 31, 85–97 (1981).
Herman, E., Young, R., & Krop, S. Doxorubicin-induced hypotension in the Beagle dog. Agents and Actions 8, 551–557 (1978).
Isner, J. M., Ferrans, V. J., Cohen, S. R., Witkind, B. G., Virmani, R., Gottdiener, J. S. & Roberts, W. C. Variability of cardiac histologic toxicity in patients treated with anthra-cycline chemotherapy. American Journal of Cardiology 45, 396 (1980).
Jaenke, R. S. An anthracycline antibiotic-induced cardiomyopathy in rabbits. Laboratory Investigation 30, 292–304 (1974).
Lambertenghi-Deliliers, G., Zanon, P. L., Pozzoli, E. F. & Bellini, O. Myocardial injury induced by a single dose of adriamycin: an electron microscopic study. Tumori 62, 517–529 (1976).
Lefrak, E. A., Pitha, J., Rosenheim, S. & Gottlieb, J. A clini-copathologic analysis of adriamycin cardiotoxicity. Cancer 32, 302–314 (1973).
Merski, A., Daskal, I., & Busch, H. Effects of adriamycin on ultrastructure of nucleoli in the heart and liver cells of the rat. Cancer Research 36, 1580–1584 (1976).
Minow, R. A., Benjamin, R. S., Lee, E. T. & Gottlieb, J. A. Adriamycin cardiomyopathy-risk factors. Cancer 39, 1397–1402 (1977).
Myers, C. E., Gianni, L., Simone, C. B., Hendrickson, M., Klecker, R.& Greene, R. Oxidative destruction of erythrocyte ghost membranes catalyzed by the doxorubicin-iron complex. Biochemistry (in press, 1982).
Myers, C. E., McGuire, W. P., Liss, R. H., Ifrim, I., Grot-zinger, K., & Young, R. G. Adriamycin: the role of lipid peroxidation in cardiac toxicity and tumor response. Science 197, 165–167 (1977).
Myers, C. E., McGuire, W. P., & Young, R. C. Adriamycin: amelioration of toxicity by a-tocopherol. Cancer Treatment Reports 60, 961–962 (1976).
Olson, H. M., Young, D. M., Prieur, D. J., LeRoy, A. F. & Reagan, R. L. Electrolyte and morphologic alterations of myocardium in adriamycin-treated rabbits. American Journal of Pathology 77, 439–454 (1974).
Regal, E., Kaliner, M., El-Hage, A., Ferrans, V. J., Kawanami, O., & Herman, E. H. Anthracycline-induced histamine release from rat mast cells. Agents and Actions (in press, 1982).
Rosenoff, S. H., Olson, H. M., Young, D. M., Bostick, F. & Young, R. C. Adriamycininduced cardiac damage in the mouse. A small animal model of cardiotoxicity. JNCI. Journal of the National Cancer Institute 55, 191–194 (1975).
Unuma, T., Senda, R., & Muramatsu, M. Mechanism of nucleolar segregation-differences in effects of actinomycin D and cycloheximide on nucleoli of rat liver cells. Journal of Electron Microscopy (Tokyo) 22, 205–216 (1973).
VanVleet, J. F. & Ferrans, V. J. Cutaneous lesions and hematologic alterations in chronic adriamycin intoxication in dogs with and without vitamin E and selenium supplementation. American Journal of Veterinary Research 41, 691–699 (1980).
VanVleet, J. F. & Ferrans, V. J. Evaluation of vitamin E and selenium protection against chronic adriamycin toxicity in rabbits. Cancer Treatment Reports 64, 315–317 (1980).
VanVleet, J. F., Ferrans, V. J. & Ruth, G. R. Ultrastructural alterations in nutritional cardiomyopathy of selenium-vitamin E deficient swine. I. Fiber lesions. Laboratory Investigation 37, 188–200 (1977).
VanVleet, J. F., Ferrans, V. J. & Ruth, G. R. Ultrastructural alterations in nutritional cardiomyopathy of selenium-vitamin E deficient swine. II. Vascular lesions. Laboratory Investigation 37, 201–211 (1977).
VanVleet, J. F., Ferrans, V. J. & Weirich, W. E. Cardiac disease induced by chronic adriamycin administration in dogs and an evaluation of vitamin E and selenium as cardioprotectants. American Journal of Pathology 99, 13–42 (1980).
VanVleet, J. F., Greenwood, L. A., & Ferrans, V. J. Pathologic features of adriamycin toxicosis in young pigs: nonskeletal lesions. American Journal of Veterinary Research 40, 1537–1552 (1979).
VanVleet, J. F., Greenwood, L., Ferrans, V. J. & Rebar, A. H. Effect of selenium-vitamin E on adriamycin-induced cardiomyopathy in rabbits. American Journal of Veterinary Research 39, 997–1010 (1978).
Von Hoff, D. D., Rozencweig, M., Layard, M., Slavik, M. & Muggia, F. M. Daunomycin-induced cardiotoxicity in children and adults. A review of 110 cases. American Journal of Medicine 62, 200–208 (1977)
Wang, Y., Madanat, F. F., Kimball, J. C., Gleiser, C. A., Ali, M. K., Kaufman, M. W. & Van Eys, J. Effect of vitamin E against adriamycin-induced toxicity in rabbits. Cancer Research 40, 1022–1027 (1980).
Young, R. C., Ozols, R. F. & Myers, C. E. The anthracycline antineoplastic drugs. New England Journal of Medicine 305, 139–153 (1981).
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1983 Plenum Press, New York
About this chapter
Cite this chapter
Ferrans, V.J. (1983). Anthracycline Cardiotoxicity. In: Spitzer, J.J. (eds) Myocardial Injury. Advances in Experimental Medicine and Biology, vol 161. Springer, Boston, MA. https://doi.org/10.1007/978-1-4684-4472-8_31
Download citation
DOI: https://doi.org/10.1007/978-1-4684-4472-8_31
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4684-4474-2
Online ISBN: 978-1-4684-4472-8
eBook Packages: Springer Book Archive